Yanbian University   Report issue

Academic/Hospital Phase 1 Phase 4
Founded: Yanji Korea, Republic of (1949)

Organization Overview

First Clinical Trial
2013
NCT01943617
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

The Affiliated Hospital of Yanbian University | Yanbian University Affiliated Hospital (Yanbian Hospital) | Yanbian University Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fibrosis (Phase 4)

Gonorrhea (Phase 4)

Liver Cirrhosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 6